NEJM sees promise in polypill for low and middle income countriesBMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39101.539352.DB (Published 25 January 2007) Cite this as: BMJ 2007;334:172
- Janice Hopkins Tanne
- 1New York
A “perspectives” commentary in the New England Journal of Medicine by a leading Indian cardiologist says that a “polypill” to combat heart disease “would be quite cost-effective in reducing the burden of cardiovascular disease even in low-income and middle-income countries” (New England Journal of Medicine 2007;356:3).
The polypill, a combination of a statin, aspirin, drugs to lower blood pressure, and folic acid, was first proposed by Nicholas Wald and M R Law of the Wolfson Institute of Preventive Medicine, Barts, and Queen Mary's School of Medicine and Dentistry at …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial